Study Regarding the Inhibition of Acetylcholinesterase by Isopropyl 4-Nitrophenyl Methylphosphonate
Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2019, Vol 14, Issue 1
Abstract
At present, many scientific institutions around the world are interested in the synthesis and improvement of new antidotes against Chemical Warfare Agents (CWAs), especially nerve agents, because of the continuous threat of the nerve agent misuse by terrorists. Few studies have been published concerning the reactivity of CWAs due to the danger of conducting such experiments, the limited laboratory supply of CWAs and the classified nature of the materials. The inherent toxicity and limited laboratory supply of CWAs has led to the development and study of safer compounds that simulate the chemistry and the reactivity of CWAs. Antidotes as Acetylcholinesterase (AChE) reactivators containing oxime groups have been demonstrated to be effective for the breakdown of nerve agents and/or their simulants. The study proposes a simulant for sarin, for experimental. Isopropyl 4-Nitrophenyl Methylphosphonate (NIMP) [1,2], a sarin simulant, was synthesized for testing the AChE inhibition capacity, in order to find it as suitable chemical simulant [3] for sarin (Figures 1 & 2). In vivo pharmacotoxicological experimental study of the above presented chemical compound was performed in order to determine its LD50 value, the degree of cholinesterase inhibition lethal doses appropriate, and the oxime assisted protective ration case of poisoning. To determine the LD50 and index protection defined as the ratio of LD50 the lot poisoning CWA simulant and treated and LD50 the lot intoxicated and untreated, there were used laboratory animals (rats Wistar) distributed in homogenous groups (intoxicated, treated and batch control). Monitoring of animals during the experiment was to record the moment signs of intoxication, mortality recording 60 minutes, 24 hours after poisoning the lots intoxicated and intoxicated and treated, tracking and recording time appearance remission signs of intoxication lots intoxicated and treated. The AChE activity was measured by using the standardised bioanalytical method performed by Eyer & Woreck in 2001. The used specimen was rat heparinised blood collected by venous punction. A UV/VIS Perkin Elmer Spectrometer equipped with soft UV KinLab. Lambda 40 was used as measuring equipment. Experimental data statistical analysis was performed by using Student’s T test and One Way Anova test. Inhibition of erythrocyte [4] AChE due to the studied compound three doses in the range of logarithmic progression of the points, showed a related to dose pharmacodynamic effect between 53% and 95%, values like those of the reference compound. NIMP doses in the range of LD50 (0.59, 0.47, and 0.31 mg/kg i.p.) leads to 95, 87, and 53% of AChE inhibition, comparable to the AChE inhibition values determined by the appropriate range LD50 of nerve agent correspondent, sarin. The experimental data are presented in the Figure 3. The calculated LD50 values by using our experimental data was 0.45 ± 0.002 mg/ kg i.p. (reference range 0.31 to 0.59 mg/kg i.p.) for NIMP. The regression equation and the correlation coefficient calculation results in NIMP LD50 are presented in the Figure 4. The determination of the protection ratio, linear regression and correlation coefficient are represented in Figure 5 and (Table 1). Conclusion The study showed that the percentage of inhibited AChE is comparable with the sarin one. Comparative analysis of LD50 values for NIMP and the correspondent nerve agent, showed lower intrinsec toxicity of the synthesized simulant. The protective ratio of antidote therapy (atropine, obidoxime) in the groups exposed to NIMP was I.P. = 2.5, value comparable with the sarin one. Also, the enzymatic AChE reactivation value was comparable to the relevant reference substance levels. Inhibiting activity of this nerve agent simulant is enough to mimic exposure to real agents, being present all the clinical signs typical of poisoning. As with aging sarin - related acetylcholinesterase, simulants show a slower rate of aging, prolonging survival time and allowing therapeutic window for reactivating oximes. Thus, it can be concluded that the compound studied shows similar pharmacodynamic effects and references due to lower intrinsic toxicity may be suitable as a simulant for research studies in the laboratory activities.
Authors and Affiliations
Raluca E Ginghina, Nicoleta Grigoriu, Mihaela Muresan, Constantin N Toader, Bogdan Patrinichi
Keywords
Related Articles
- EP ID EP584654
- DOI 10.26717/BJSTR.2019.14.002539
- Views 179
- Downloads 0
Cochlear Implants and Classroom Learning among Deaf College Students
Previous studies have demonstrated that early academic benefits associated with cochlear implant (CI) use during the primary school years are attenuated or absent among secondary school and college students, at least whe...
Why should we perform hemodynamic ramp test following left ventricular assist device implantation?
Left ventricular assist device (LVAD) is a strong therapeutic tool to improve survival in patients with advanced heart failure, whereas not a few patients have potentially abnormal hemodynamics despite LVAD supports. Hem...
Biosurfactant As the Next Antimicrobial Agents in Pharmaceutical Applications
The number of patients with antimicrobial resistance is growing as a result of new emerging microbes or overuse of antibiotics. A new substitute to the existing antimicrobial agents is important in time to come to contro...
Methomyl-Induced Acute Poisoning in Industrial Workers: Five Case Reports
Aim: To understand the poisoning and mechanism of methomyl. Methods: To collect the data of occupational history, case data, auxiliary examination and so on, and to present the diagnosis results of occupational diseases...
The Smile Aesthetics and its Implications in Social Prosthetic Rehabilitations: A Case Report
The aim of this study is to individualize the correlative aspects between the type of smile , the degree of visibility of the teeth and the way in which the chosen therapeutic solution, in accordance with the particulari...